InspireMD to Announce Second Quarter 2026 Financial Results
Rhea-AI Summary
InspireMD (Nasdaq:NSPR) announced it will release its second quarter 2026 financial results on Monday, August 17, 2026. In conjunction, the company will host a conference call and live audio webcast at 8:30 a.m. Eastern Time to review results and recent highlights.
Investors can participate by phone after registering through an online form, which provides dial-in details and a personal PIN via email. A live webcast and archived replay will be accessible through the Investors section of InspireMD’s website, with participants encouraged to register at least 15 minutes before the call.
Positive
- None.
Negative
- None.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 27 | earnings date announcement | Neutral | -5.8% | Announced first-quarter 2026 results release date and conference call |
| Mar 09 | earnings date announcement | Neutral | +0.6% | Announced fourth-quarter and full-year 2025 results release date |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings-date announcements showed mixed reactions, including a negative 5.79% move and a positive 0.61% move.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced it will issue its press release for its second quarter financial results on Monday August 17, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Parties interested in participating by phone should register using this online form. After registering for the webcast, dial-in details will be provided in an auto-generated e-mail containing a link to the conference phone number along with a personal pin. A live audio webcast and an archive of the recording will be available here and through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com. Interested participants are encouraged to register more than 15 minutes before the start of the call.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com